LINC00152/miR-145-5p/KLF4 ceRNA Axis: Diagnostic and Prognostic Value in Aortic Dissection

IF 2.2 4区 医学 Q4 IMMUNOLOGY
Apmis Pub Date : 2026-08-23 DOI:10.1111/apm.70248
Xiaomei Guan, Jun Li
{"title":"LINC00152/miR-145-5p/KLF4 ceRNA Axis: Diagnostic and Prognostic Value in Aortic Dissection","authors":"Xiaomei Guan,&nbsp;Jun Li","doi":"10.1111/apm.70248","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Aortic dissection (AD) is a fatal cardiovascular emergency. This study explored the clinical value and mechanism of the LINC00152/miR-145-5p/KLF4 ceRNA axis in AD. 105 <span>ad</span> patients and 55 healthy controls were enrolled. LINC00152, miR-145-5p, and KLF4 levels were measured by qRT-PCR. ROC and Cox regression analyses assessed diagnostic and prognostic value. Dual-luciferase reporter and rescue experiments in Ang II-induced HASMCs validated the ceRNA axis. As a result, LINC00152 and KLF4 were upregulated, while miR-145-5p was downregulated in AD patients. The three molecules showed good diagnostic efficacy (combined AUC = 0.9087). LINC00152, KLF4, and their joint risk signature were independent prognostic factors for adverse outcomes. Mechanistically, LINC00152 sponged miR-145-5p to upregulate KLF4, promoting pro-inflammatory factors (TNF-α, IL-1β) and matrix metalloproteinases (MMP-2, MMP-9) in HASMCs. In conclusion, the LINC00152/miR-145-5p/KLF4 ceRNA axis shows preliminary diagnostic and prognostic potential for AD, and drives AD development by regulating vascular inflammation and extracellular matrix degradation, which may serve as a candidate molecular target for subsequent translational research.</p>\n </div>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"134 8","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2026-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Apmis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apm.70248","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aortic dissection (AD) is a fatal cardiovascular emergency. This study explored the clinical value and mechanism of the LINC00152/miR-145-5p/KLF4 ceRNA axis in AD. 105 ad patients and 55 healthy controls were enrolled. LINC00152, miR-145-5p, and KLF4 levels were measured by qRT-PCR. ROC and Cox regression analyses assessed diagnostic and prognostic value. Dual-luciferase reporter and rescue experiments in Ang II-induced HASMCs validated the ceRNA axis. As a result, LINC00152 and KLF4 were upregulated, while miR-145-5p was downregulated in AD patients. The three molecules showed good diagnostic efficacy (combined AUC = 0.9087). LINC00152, KLF4, and their joint risk signature were independent prognostic factors for adverse outcomes. Mechanistically, LINC00152 sponged miR-145-5p to upregulate KLF4, promoting pro-inflammatory factors (TNF-α, IL-1β) and matrix metalloproteinases (MMP-2, MMP-9) in HASMCs. In conclusion, the LINC00152/miR-145-5p/KLF4 ceRNA axis shows preliminary diagnostic and prognostic potential for AD, and drives AD development by regulating vascular inflammation and extracellular matrix degradation, which may serve as a candidate molecular target for subsequent translational research.

LINC00152/miR-145-5p/KLF4 ceRNA轴:主动脉夹层的诊断和预后价值。
主动脉夹层是一种致命的心血管急症。本研究探讨了LINC00152/miR-145-5p/KLF4 ceRNA轴在AD中的临床价值和作用机制。105例ad患者和55名健康对照者入组。采用qRT-PCR检测LINC00152、miR-145-5p和KLF4水平。ROC和Cox回归分析评估诊断和预后价值。在Ang ii诱导的HASMCs中进行的双荧光素酶报告和修复实验验证了ceRNA轴。因此,在AD患者中,LINC00152和KLF4上调,而miR-145-5p下调。3种分子具有较好的诊断效果(联合AUC = 0.9087)。LINC00152、KLF4及其联合风险标志是不良结局的独立预后因素。在机制上,LINC00152海绵miR-145-5p上调KLF4,促进hasmc中的促炎因子(TNF-α, IL-1β)和基质金属蛋白酶(MMP-2, MMP-9)。综上所述,LINC00152/miR-145-5p/KLF4 ceRNA轴显示出AD的初步诊断和预后潜力,并通过调节血管炎症和细胞外基质降解来驱动AD的发展,可能作为后续转化研究的候选分子靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Apmis
Apmis 医学-病理学
CiteScore
5.20
自引率
0.00%
发文量
91
审稿时长
2 months
期刊介绍: APMIS, formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica, has been published since 1924 by the Scandinavian Societies for Medical Microbiology and Pathology as a non-profit-making scientific journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书